Base de dados : HANSEN
Pesquisa : RESULTADO DE TRATAMENTO [Descritor de assunto]
Referências encontradas : 51 [refinar]
Mostrando: 1 .. 20   no formato [Detalhado]

página 1 de 3 ir para página          

  1 / 51 HANSEN  
              next record last record
seleciona
para imprimir
Id:25252
Autor:Frist, Thomas F
Título:Community factors influencing the Hansen's disease patient and his treatment
..-
Fonte:s.l; s.n; 1980. 7 p. .
Descritores:PERCEPCAO SOCIAL
CONTROLES INFORMAIS DA SOCIEDADE/clas
CONTROLES INFORMAIS DA SOCIEDADE/hist
HANSENIASE/prev
HANSENIASE/psicol
HANSENIASE/terap
RESULTADO DE TRATAMENTO
CONFORMIDADE SOCIAL
 ACEITACAO SOCIAL
 MEIO SOCIAL
 FACILITACAO SOCIAL
 PRECONCEITO
 AJUSTAMENTO SOCIAL
 ISOLAMENTO SOCIAL/psicol
 RELACOES INTERPESSOAIS
Limites:HUMANO
Localização:BR191.1; 00471/s


  2 / 51 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:25096
Autor:Mathew, D; Kishore, B. Nanda ; Shwethadri, G. K; Sukumar; Shetty, N. J
Título:An evaluation of clinical and histopathological status in paucibacillary leprosy patients after completion of sixed duration therapy
..-
Fonte:s.l; s.n; 2004. 8 p. tab.
Resumo:The presente study was carried out involving 25 patients with paucibacillary leprosy who attended the outpatient department of dermatology of Father Muller's Medical College Hospital during the period January 2001 to March 2002. All the patients were examined clinically and histopathologically at the beginning and at the end of six months of MDT and relevant data recorded. Clinicopathological correlation with histopathological classification before MDT was 72% and 68% at the end of MDT in our study. At the end of treatment 4 (16%) cases were clinically active and 8 (32%) were histopathologically active. The study showed that active cases were siginificantly reduced as a result of MDT, both clinically and histopatologically. The histopathological activity that outlasts MDT may be due to the bacillary fragments that persist; but clincial activity coupled with histopathological activity seen in 2 patients at the end of 6 months of MDT was possibly an indicator of relapse and these patients and similar others need to be follewed up for a longer duration. Is this study, resolution of granuloma and clinical activity after completion of MDT were assessed (AU).
Descritores:HANSENIASE TUBERCULOIDE/compl
HANSENIASE TUBERCULOIDE/patol
HANSENIASE TUBERCULOIDE/fisiopatol
HANSENIASE TUBERCULOIDE/terap
RESULTADO DE TRATAMENTO
HANSENOSTATICOS/admin
HANSENOSTATICOS/farmacol
HANSENOSTATICOS/uso terap
QUIMIOTERAPIA COMBINADA
HANSENIASE/clas
 HANSENIASE/diag
 HANSENIASE/terap
Limites:HUMANO
Localização:BR191.1; 08999/s


  3 / 51 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:25087
Autor:Meima, Abraham; Smith, W. Carins S; Van Oortmarssen, Gerrit J; Richardus, Jan H; Habbema, J. Dik F
Título:The future incidence of leprosy: a scenario analysis
..-
Fonte:s.l; s.n; 2004. 8 p. tab, graf.
Resumo:Objective: To investigate the impact of the current strategy fot the elimination of leprosy on its incidence and to assess the consequences of failure to sustain this strategy. Methods: Scenarios for assessing the impact of the elimination strategy were implemented in a coputer simulation program. The scenarios reflected the assumptions made regarding contagiousness, transmission and bacille Calmet-Guerin (BCG) vaccination. The trend in case detection rate for the main countries in which leprosy was endemic during 1985-98 was fitted, and incidence up to 2020 was projected. Findings: Owing to the gradual shortening of delays in detection up to 1998, and because of the low relapse rate that occurs with multidrug treatment MDT, incidence is predicted to decrease beyond 2000 in all scenarios. The annual decline was a few per cent higher when favourable assumptions were made about protection and coverage of BCG vaccination. Overall, the predicted annual decline in incidences ranged from 2% to 12%. Conclusions: The elimination strategy reduces transmission, but the decline amy be slow. Relaxation of control after 2005 is unjustified given the uncertainty about the rate of decline and the adverse effects of longer delays in detection. A long-term strategy for leprosy control should be adopted (AU).
Descritores:HANSENIASE/diag
HANSENIASE/epidemiol
HANSENIASE/terap
QUIMIOTERAPIA COMBINADA
RESULTADO DE TRATAMENTO
QUIMIOTERAPIA/tend
 QUIMIOTERAPIA/util
 VACINA BCG/uso terap
 SIMULACAO POR COMPUTADOR/estatíst
 SIMULACAO POR COMPUTADOR/util
Limites:HUMANO
Localização:BR191.1; 09191/s


  4 / 51 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:24859
Autor:Baccaredda Boy, A & G Farris
Título:Treatment of leprosy with viomycin pyrazinamide and cycloserine
ver-
Fonte:Genova; s.n; 1958. 3 p. .
Descritores:HANSENIASE VIRCHOWIANA/terap
VIOMICINA/admin
VIOMICINA/farmacol
VIOMICINA/tox
VIOMICINA/uso
terap
PIRAZINAMIDA/admin
PIRAZINAMIDA/farmacol
PIRAZINAMIDA/tox
PIRAZINAMIDA/uso terap
RESULTADO DE TRATAMENTO
 TOXICIDADE DE DROGAS
 AVALIACAO DE MEDICAMENTOS/métodos
 AVALIACAO DE MEDICAMENTOS/util
Limites:HUMANO
Localização:BR191.1; 01494/s


  5 / 51 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:22736
Autor:Yan, Liangbin; Zhang, Guocheng; Zheng, Zhiju; Wenzhong, Li; Zheng, Tisheng; Watson, Jean M; Piefer, Angelina
Título:Comprehensive treatment of complicated plantar ulcers in leprosy
..-
Fonte:s.l; s.n; 2003. 3 p. .
Resumo:OBJECTIVE: To investigate feasible treatment methods for plantar ulcers in leprosy patients according to the agreement between the Ministry of Health (MOH) of China and the Leprosy Mission International (LMI). METHODS: A total of 2599 complicated foot ulcers in 1804 leprosy cases underwent surgic treatment. Plastic fixation and supports were used, dressings were changed regularly, and protective footwear and modified insoles were provided. RESULTS: Of the 2599 foot ulcers 1446 (55.64%) healed. The cure rate of the patients treated in leprosy hospitals was 71.31%, with 219 (15.15%) recurrences of foot ulcers. The recurrence rate of those who lived at home was 18.35%. CONCLUSIONS: Comprehensive treatment of foot ulcers has a high cure rate and a low recurrence rate. Reduction of workload, avoidance of long distance walking, intensification of education on foot self-care and provision of financial support are the main measures for preventing a recurrence of foot ulcers. (AU).
Descritores:Ulcera do Pé/*TH
Hanseníase/*CO
Resultado de Tratamento
Limites:Humano
Localização:BR191.1; 02015/s


  6 / 51 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:22732
Autor:Zapor, Michael; Kaplan, Keith; Hawkes, Clifton
Título:Apparent exacerbation of Hansen's disease despite appropriate antimicrobial therapy
..-
Fonte:s.l; s.n; 2003. 3 p. ilus.
Resumo:In 1991, the World Health Organization and its member states resolved to reduce the global prevalence of Hansen's disease (leprosy) by at least 90%. Despite its waning prevalence, however, the disease remains endemic in parts of Africa, Asia, and Latin America. Moreover, imported cases are occasionally encountered innonendemic areas. This fact, coupled with the current tempo of overseas deployments, makes it imperative that military physicians familiarize themselves with both the presentation and potential complications of Hansen's disease. Here, we present the case of a soldier referred to Walter Reed Army Medical Center for apparent worsening of his disease despite appropriate antibiotic therapy. On evaluation, the patient was diagnosed with reversal reaction, an immune-mediated phenomenon resembling disease exacerbation and requiring prompt intervention to avert lasting sequelae. Following the case presentation, we discuss the clinical manifestations, pathophysiology, and management of reversal reactions as well as the related entity erythema nodosum leprosum. (AU).
Descritores:Dapsona/*TU
Hanseníase Tuberculóide/*DI/*DT
Rifampina/*TU
Resultado de Tratamento
Limites:Adulto
Humano
Masculino
Localização:BR191.1; 00255/s


  7 / 51 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18990
Autor:Carsalade, Georges-Yves de; Achirafi, Aboubacar; Flageul, Béatrice
Título:Pentoxifylline in the treatment of erythema nodosum leprosum
..-
Fonte:s.l; s.n; Jan. 2003. 5 p. tab.
Resumo:Erythema nodosum leprosum (ENL) is a well-known serious complication affecting 10 per cent of lepromatous multibacillary leprosy patients. In the chronic form, its morbidity may be considerable. Thalidomide and systemic steroids are the two current effective drugs for the management of ENL. However, their use in endemic countries is often difficult and hazardous, and a search for new therapies is needed. We report our experience on the effects of pentoxifylline, a methylxanthine derivative, which has recently been suggested as a possible effective treatment for ENL attacks. (AU).
Descritores:ERITEMA NODOSO/quimioter
ERITEMA NODOSO/patol
ESQUEMA DE MEDICACAO
ADMINISTRACAO ORAL
HANSENOSTATICOS/admin
HANSENOSTATICOS/uso terap
HANSENIASE VIRCHOWIANA/quimioter
HANSENIASE VIRCHOWIANA/patol
PENTOXIFILINA/admin
PENTOXIFILINA/uso terap
INDICE DE GRAVIDADE DE DOENCA
RESULTADO DE TRATAMENTO
Limites:HUMANO
MASCULINO
FEMININO
ADULTO
ADOLESCENTE
Meio Eletrônico: - .
Localização:BR191.1; 09150/s


  8 / 51 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18983
Autor:Kiriyama, Isao; Ohgaki, Kenji; Ohba, Shuji; Egawa, Katushi; Nishimura, Taiji
Título:Prostate cancer in patients with Hansen's disease
..-
Fonte:s.l; s.n; 2003. 3 p. tab.
Resumo:Hansen's disease causes testicular failure secondarily, and because of this, it has been considered that prostate cancer would not be found in association. Three of 14 patients with chronic leprosy in Suruga National Sanatorium Hansen's Disease Hospital were found to have prostate cancer. A 72-year-old with lepromatous leprosy was diagnosed with stage T3a prostate cancer and treated with radical prostatectomy after hormonal therapy, plus irradiation. An 80-year-old with lepromatous leprosy was diagnosed with stage T2 prostate cancer and treated with irradiation and follow up only without hormone therapy and surgery because of his low testosterone level and old age. An 82-year-old with borderline leprosy was diagnosed with stage T1c prostate cancer and because of the pathological finding of low Gleason score and his old age, he was treated with hormonal therapy only. Two of the three cases had elevated concentrations of follicle-stimulating hormone and luteinizing hormone, which suggests that their prostatic cancers might have been equivalent to be under the influence of hormone therapy. Therefore, in aged male patients with Hansen's disease, the follicle-stimulating hormone, luteinizing hormone and testosterone concentrations should be measured, as well as that of prostate-specific antigen, and a prostate biopsy should be also considered if the prostate-specific antigen concentration is increased, even with hypogonadism. (AU).
Descritores:ANTINEOPLASICOS HORMONAIS/uso terap
HANSENIASE DIMORFA/compl
HANSENIASE VIRCHOWIANA/compl
ANTIGENO PROSTATICO ESPECÍFICO/anal
ADENOCARCINOMA/diag
ADENOCARCINOMA/etiol
ADENOCARCINOMA/terap
ESTADIAMENTO DE NEOPLASIAS
PROSTATECTOMIA
NEOPLASIAS PROSTATICAS/diag
NEOPLASIAS PROSTATICAS/etiol
NEOPLASIAS PROSTATICAS/terap
RESULTADO DE TRATAMENTO
Limites:RELATO DE CASO
HUMANO
MASCULINO
IDOSO
IDOSO DE 80 ANOS OU MAIS
Meio Eletrônico: - .
Localização:BR191.1; 09093/s


  9 / 51 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18974
Autor:Richard, B. M
Título:Location of the extracranial extent of leprous facial nerve pathology may allow leprous facial palsy to be reanimated by free muscle transfer
..-
Fonte:s.l; s.n; 2003. 7 p. ilus.
Resumo:Leprosy is a mycobacterial nerve and skin infection, which can be eradicated by antibiotics. Some patients affected by leprosy, once cured, have residual nerve impairment with paralysis and sensory neuropathy. A series of patients with facial nerve paralysis, investigated using clinical, histological and electrophysiological techniques, demonstrated that the nerve pathology was distal to the section of main trunk prior to its bifurcation. Facial reanimation was achieved with a free gracilis-muscle transfer, coapting its motor nerve to the ipsilateral facial nerve trunk proximal to the site of the leprosy pathology, with a moderate clinical result. (AU).
Descritores:PARALISIA FACIAL/microbiol
PARALISIA FACIAL/cirurg
ELETROMIOGRAFIA/métodos
HANSENIASE DIMORFA/compl
HANSENIASE DIMORFA/quimioter
HANSENIASE TUBERCULOIDE/compl
HANSENIASE TUBERCULOIDE/quimioter
COMPLICACOES POS-OPERATÓRIAS/etiol
RESULTADO DE TRATAMENTO
MUSCULO ESQUELETICO/transpl
Limites:RELATO DE CASO
HUMANO
MASCULINO
ADULTO
Meio Eletrônico: - .
Localização:BR191.1; 09089/s


  10 / 51 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18917
Autor:Bari, M. M
Título:Surgical reconstruction of leprotic foot drop
..-
Fonte:s.l; s.n; 2003. 2 p. tab.
Resumo:We have operated 152 patients for correction of foot-drop due to leprosy from March 1992 to July 1999. The method used was circumtibial transfer of the tibial is posterior to the tendons of extensor hellucis longus and the extensor digitorum longus in the foot together with lengthening of the Achilles tendon. The results were satisfactory in 135 of these cases as judged by adequate restoration of heel--toe gait and of active dorsiflexion. The follow up period ranged from 6 months to 8 years. Inadequate post-operative physiotherapy was the reason for unsatisfactory results in seventeen cases. (AU).
Descritores:TENDAO DO CALCANEO/SU
SEGUIMENTOS
DEFORMIDADES ADQUIRIDAS DO PE/*ET/*SU
HANSENIASE/*CO
PARALISIA/ET/SU
AMPLITUDE DE MOVIMENTO ARTICULAR
PROCEDIMENTOS CIRURGICOS RECONSTRUTIVOS/*MT/RH
RECUPERACAO DE FUNCAO FISIOLOGICA
TRANSFERENCIA DE TENDAO/MT/RH
RESULTADO DE TRATAMENTO
Limites:ADOLESCENTE
ADULTO
CRIANCA
FEMININO
HUMANO
MASCULINO
MEIA-IDADE
Localização:BR191.1; 09110/s


  11 / 51 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18579
Autor:Kumagai, Masaru; Yokota, Kimagai; Endoh, Toshiya; Takemoto, Hitoshi; Nagata, Kensei
Título:Charcot joint-like changes following ankle fracture in a patient with no underlyng disease: report of a rare case
..-
Fonte:s.l; s.n; 2002. 4 p. ilus.
Resumo:Charcot joint is a disease that often occurs in patients with diabetes mellitus, tabes dorsalis, syringomyelia, chronic alcoholism, leprosy, trauma, or infection after fractures and dislocations. The treatment for Charcot joint has various complications, such as skin lesions, infections, and delayed union. We present our experience with a male patient who developed Charcot joint-like changes without diabetes mellitus or any other disease after an ankle fracture due to minor trauma. (AU).
Descritores:ACIDENTES POR QUEDAS
RESULTADO DE TRATAMENTO
MEDICAO DE RISCO
AMPLITUDE DE MOVIMENTO ARTICULAR/fisiol
SEGUIMENTOS
ARTROPATIA NEUROGÊNICA/etiol
ARTROPATIA NEUROGÊNICA/patol
ARTROPATIA NEUROGÊNICA/cirurg
FRATURAS/compl
FRATURAS/radiogr
FRATURAS/reabil
TRAUMATISMOS DO TORNOZELO/compl
TRAUMATISMOS DO TORNOZELO/radiogr
TRAUMATISMOS DO TORNOZELO/reabil
PROCEDIMENTOS ORTOPEDICOS/métodos
APARELHOS ORTOPEDICOS
ESCALA DE GRAVIDADE DO FERIMENTO
 IMAGEM POR RESSONÂNCIA MAGNETICA
 RECUPERACAO DE FUNÇÃO FISIOLOGICA
Limites:RELATO DE CASO
HUMANO
MASCULINO
ADULTO
Meio Eletrônico: - .
Localização:BR191.1; 09025/s


  12 / 51 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18492
Autor:Turkof, Edvin; Richard, Bruce; Assadian, Ojan; Khatri, Bharat; Knolle, Erich; Lucas, Sebastian
Título:Leprosy affects facial nerves in a scattered distribution from the main trunk to all peripheral branches and neurolysis improves muscle function of the face
..-
Fonte:s.l; s.n; 2003. 8 p. ilus, tab, graf.
Resumo:Current literature rejects nerve release in leprous facial neuropathy and states that lesions are restricted to the peripheral zygomatic branches. Since there are approximately 500,000 patients with this disease throughout the world, we wanted to clarify the precise location of facial nerve's affection and the benefit of neurolysis. Our study showed that in patients with leprosy, the facial nerve's main trunk, the peripheral zygomatic branches, and all other branches were affected. Follow-up showed improvement in lagophthalmos and in misreinnervation, with no improvement in the control cohort. Nerve release improves muscle function in leprous facial neuropathy, provided surgery is performed on all affected segments. Intraoperative electroneurodiagnostics is an effective tool for detecting the most proximal site of lesion and ensuring effective surgery. (AU).
Descritores:ESTUDOS DE COORTES
ESTIMULACAO ELETRICA
ELETROFISIOLOGIA
MUSCULOS FACIAIS/inerv
MUSCULOS FACIAIS/fisiol
NERVO FACIAL/patol
NERVO FACIAL/fisiol
NERVO FACIAL/fisiopatol
HANSENIASE DIMORFA/patol
HANSENIASE DIMORFA/fisiopatol
HANSENIASE DIMORFA/cirurg
NERVOS PERIFERICOS/patol
NERVOS PERIFERICOS/cirurg
RESULTADO DE TRATAMENTO
PERIODO INTRA-OPERATORIO
 CONDUCAO NERVOSA
Limites:HUMANO
MASCULINO
FEMININO
ADULTO
MEIA-IDADE
SUPPORT, NON-U.S. GOV'T
Meio Eletrônico: - .
Localização:BR191.1; 09072/s


  13 / 51 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:17503
Autor:Brunet, Robert C; Struchiner, Claudio J; Loinaz, Arik
Título:A method for estimating time depedent intervention benefits under arbitrarily varying age and exogenous components of hazard
..-
Fonte:s.l; s.n; 2001. 16 p. ilus, tab, graf.
Descritores:MEDIÇÃO DE RISCO
FATORES DE RISCO
FATORES DE TEMPO
METODOLOGIA
RISCO
 COMPORTAMENTO DE REDUÇÃO DO RISCO
 RESULTADO DE TRATAMENTO
Localização:BR191.1; 08969/s


  14 / 51 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:17499
Autor:Peters, E. J; Ansa, V. O; Imananagha, K. K; Antia, E. A
Título:Time of presentation for treatment and profile of deformities among leprosy patients in South Eastern Nigeria
..-
Fonte:s.l; s.n; 2001. 5 p. tab, graf.
Descritores:RESULTADO DE TRATAMENTO
HANSENÍASE/quimioterapia
HANSENÍASE/complicações
SISTEMA NERVOSO PERIFÉRICO/lesões
Localização:BR191.1; 08965/s


  15 / 51 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:16401
Autor:Blatt, Jucelene Marchi
Título:Considerações acerca dos estados reacionais do portador de hanseníase no município de Itajaí
Considerations on reactional states of Itajai's hansen's carriers-
Fonte:s.l; s.n; 2001. 10 p. tab.
Descritores:HANSENIASE
PROGRAMAS MÉDICOS REGIONAIS
AVALIAÇAO DE PROCESSOS E RESULTADOS (CUIDADOS DE SAUDE)
RESULTADO DE TRATAMENTO
REGISTROS MÉDICOS
MYCOBACTERIUM LEPRAE
TALIDOMIDA
CLOFAZIMINA
RIFAMPINA
DAPSONA
ANTICORPOS ANTIBACTÉRIAS
RELAÇAO DOSE-RESPOSTA IMUNOLOGICA
Localização:BR191.1; 08738/s


  16 / 51 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:16373
Autor:Freerksen, Enno; Rosenfeld, Magdalena; Depasquale, George; Bonnici, Edgar; Gatt, Paul
Título:The Malta Project - A country freed itself of leprosy: a 27-year progress study (1972-1999) of the first successful eradication of leprosy
..-
Fonte:s.l; s.n; 2001. 23 p. tab, graf.
Descritores:TERAPIA COMBINADA
DAPSONA
ISONIAZIDA
LEPROSTATICOS
HANSENIASE
HANSENIASE
MALTA
AVALIAÇAO DE PROGRAMAS
PROTIONAMIDA
SAUDE PUBLICA
RIFAMPINA
RESULTADO DE TRATAMENTO
Localização:BR191.1; 08632/s


  17 / 51 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:16362
Autor:Courtright, Paul; Lewallen, Susan; Tungpakorn, Narong; Cho, Byeong-Hee; Lim, Young-Kyu; Lee, Hyun-Ji; Kim, Sung-Hwa
Título:Cataract in leprosy patients: cataract surgical coverage, barriers to acceptance of surgery, and outcome of surgery in a population based survey in Korea
..-
Fonte:s.l; s.n; 2001. 4 p. tab.
Descritores:ATITUDE DO PESSOAL DE SAUDE
ATITUDE FRENTE A SAUDE
CATARATA
CATARATA
EXTRAÇAO DE CATARATA
EFEITOS PSICO-SOCIAIS DA DOENÇA
OCULOS
ACESSO AOS SERVIÇOS DE SAUDE
CORÉIA (GEOGRAFICO)
HANSENIASE
AVALIAÇAO DE PROGRAMAS
ERROS DE REFRAÇAO
ERROS DE REFRAÇAO
RESULTADO DE TRATAMENTO
ACUIDADE VISUAL
Localização:BR191.1; 08677/s


  18 / 51 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:16014
Autor:Mujagic, Hamza; Chabner, Bruce A; Mujagic, Zlata
Título:Mechanisms of action and potential therapeutic uses of thalidomide
..-
Fonte:s.l; s.n; 2002. 12 p. tab.
Descritores:MIELOMA MULTIPLO
MIELOMA MULTIPLO
NEOPLASIAS
NEOPLASIAS
DEFEITOS DO TUBO NEURAL
DEFEITOS DO TUBO NEURAL
SENSIBILIDADE E ESPECIFICIDADE
RELAÇAO ESTRUTURA-ATIVIDADE
TALIDOMIDA
TALIDOMIDA
TALIDOMIDA
RESULTADO DE TRATAMENTO
Localização:BR191.1; 08595/s


  19 / 51 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:15809
Autor:Oliver, Stephen J; Kikuch, Toyoko; Krueger, James G; Kaplan, Gilla
Título:Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement
..-
Fonte:s.l; s.n; 2002. 11 p. ilus, tab, graf.
Descritores:ANTIGENOS CD
CÉLULAS DENDRITICAS
AGENTES DERMATOLOGICOS
AGENTES DERMATOLOGICOS
CITOMETRIA DE FLUXO
ANTIGENOS HLA-DR
IMUNOHISTOQUIMICA
IMUNOSSUPRESSORES
INTERLEUCINA-12
INTERLEUCINA-2
CÉLULAS DE LANGERHANS
SARCOIDOSE
SARCOIDOSE
SARCOIDOSE
DERMATOPATIAS
DERMATOPATIAS
DERMATOPATIAS
LINFOCITOS T
TALIDOMIDA
TALIDOMIDA
RESULTADO DE TRATAMENTO
FATOR DE NECROSE DE TUMOR
Localização:BR191.1; 08523/s


  20 / 51 HANSEN  
              first record previous record
seleciona
para imprimir
Id:15694
Autor:Mujagic, Hamza; Chabner, Bruce A; Mujagic, Zlata
Título:Mechanisms of action and potential therapeutic uses of thalidomide
..-
Fonte:s.l; s.n; 2002. 12 p. tab.
Descritores:TALIDOMIDA
TALIDOMIDA
TALIDOMIDA
ENSAIOS CLINICOS
MIELOMA MULTIPLO
MIELOMA MULTIPLO
NEOPLASIAS
NEOPLASIAS
DEFEITOS DO TUBO NEURAL
DEFEITOS DO TUBO NEURAL
SENSIBILIDADE E ESPECIFICIDADE
RELAÇAO ESTRUTURA-ATIVIDADE
RESULTADO DE TRATAMENTO
Localização:BR191.1; 08505/s



página 1 de 3 ir para página          
   


Refinar a pesquisa
  Base de dados : HANSEN Formulário avançado   
Pesquisar por : Formulário livre   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information